Maarten Nauta

Maarten Nauta

Auto-generated profile, based on publicly available information

Maarten Nauta

Statens Serum Institut

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in EFSA Journal
Verified
Journal Article
Open access
PDF file
E(Efsa Panel On Biological Hazards (Biohaz)
Efsa Panel On Biological Hazards (Biohaz)
KKKostas Koutsoumanis
Kostas Koutsoumanis
AAAna Allende
Ana Allende
AAAvelino Alvarez‐Ordóñez
Avelino Alvarez‐Ordóñez
DBDeclan Bolton
Declan Bolton
LHLieve Herman
Lieve Herman
The qualified presumption of safety (QPS) was developed to provide a safety pre‐assessment within EFSA for microorganisms. Strains belonging to QPS taxonomic units (TUs) still require an assessment b...

1 June 2000 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
MNMaarten J. Nauta
Maarten J. Nauta

1 January 2020 in EFSA Journal
Verified
Journal Article
Open access
PDF file
EPEfsa Biohaz Panel
Efsa Biohaz Panel
KKKostas Koutsoumanis
Kostas Koutsoumanis
AAAna Allende
Ana Allende
AAAvelino Alvarez‐Ordóñez
Avelino Alvarez‐Ordóñez
SBSara Bover-Cid
Sara Bover-Cid
DBDeclan Bolton
Declan Bolton
The provisional molecular approach, proposed by EFSA in 2013, for the pathogenicity assessment of Shiga toxin‐producing Escherichia coli (STEC) has been reviewed. Analysis of the confirmed reported h...

1 February 2009 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
MNMaarten Nauta
Maarten Nauta
AHAndy Hill
Andy Hill
HRHanne Rosenquist
Hanne Rosenquist
SBSigrid Brynestad
Sigrid Brynestad
AFAlexandra Fetsch
Alexandra Fetsch
AHArie Havelaar
Arie Havelaar

1 February 2019 in EFSA Journal
Verified
Journal Article
Open access
PDF file
EPEfsa Panel On Biological Hazards (Efsa Biohaz Panel)
Efsa Panel On Biological Hazards (Efsa Biohaz Panel)
KKKostas Koutsoumanis
Kostas Koutsoumanis
AAAna Allende
Ana Allende
AAAvelino Alvarez‐Ordóñez
Avelino Alvarez‐Ordóñez
DBDeclan Bolton
Declan Bolton
RDRobert Davies
Robert Davies
An increase in confirmed human salmonellosis cases in the EU after 2014 triggered investigation of contributory factors and control options in poultry production. Reconsideration of the five current target serovars for breeding hens showed that there is justification for retaining Salmonella Enteritidis, Salmonella Typhimurium (including monophasic variants) and Salmonella Infantis, while Salmonella Virchow and Salmonella Hadar could be replaced by Salmonella Kentucky and either Salmonella Heidelberg, Salmonella Thompson or a variable serovar in national prevalence targets. However, a target that incorporates all serovars is expected to be more effective as the most relevant serovars in breeding flocks vary between Member State (MS) and over time. Achievement of a 1% target for the current target serovars in laying hen flocks is estimated to be reduced by 254,400 CrI95[98,540; 602,700] compared to the situation in 2016. This translates to a reduction of 53.4% CrI95[39.1; 65.7] considering the layer‐associated human salmonellosis true cases and 6.2% considering the overall human salmonellosis true cases in the 23 MSs included in attribution modelling. A review of risk factors for Salmonella in laying hens revealed that overall evidence points to a lower occurrence in non‐cage compared to cage systems. A conclusion on the effect of outdoor access or impact of the shift from conventional to enriched cages could not be reached. A similar review for broiler chickens concluded that the evidence that outdoor access affects the occurrence of Salmonella is inconclusive. There is conclusive evidence that an increased stocking density, larger farms and stress result in increased occurrence, persistence and spread of Salmonella in laying hen flocks. Based on scientific evidence, an impact of Salmonella control programmes, apart from general hygiene procedures, on the prevalence of Campylobacter in broiler flocks at the holding and on broiler meat at the end of the slaughter process is not expected.

13 April 2012 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
AHA. H. Havelaar
A. H. Havelaar
SIS. Ivarsson
S. Ivarsson
MLM. Löfdahl
M. Löfdahl
MNM. J. Nauta
M. J. Nauta
SUMMARY: We estimated the true incidence of campylobacteriosis and salmonellosis in the European Union (EU) in 2009. The estimate was based on disease risks of returning Swedish travellers, averaged over the years 2005–2009, and anchored to a Dutch population-based study on incidence and aetiology of gastroenteritis. For the 27 EU member states the incidence of campylobacteriosis was about 9·2 (95% CI 2·8–23) million cases, while the incidence of salmonellosis was 6·2 (95% CI 1·0–19) million cases. Only 1/47 (95% CI 14–117) cases of campylobacteriosis and one 1/58 (95% CI 9–172) cases of salmonellosis were reported in the EU. The incidence rate of campylobacteriosis in EU member states varied between 30 and 13 500/100 000 population and was significantly correlated with the prevalence of Campylobacter spp. in broiler chickens. The incidence rate of salmonellosis in EU member states varied between 16 and 11 800/100 000 population and was significantly correlated with the prevalence of Salmonella Enteritidis in laying hens.